Similar articles

• The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.

  Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ. Jacobs V, et al. Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26. Heart Rhythm. 2015. PMID: 25546809
• Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.

  Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM. Tu HT, et al. Cerebrovasc Dis. 2013;36(4):273-80. doi: 10.1159/000353670. Epub 2013 Oct 16. Cerebrovasc Dis. 2013. PMID: 24135809
• [Atrial fibrillation and stroke].

  Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D. Aamodt AH, et al. Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850. Tidsskr Nor Laegeforen. 2013. PMID: 23929293 Review. Norwegian.
• Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation.

  Stroke Risk in Atrial Fibrillation Working Group. Stroke Risk in Atrial Fibrillation Working Group. Stroke. 2008 Jun;39(6):1901-10. doi: 10.1161/STROKEAHA.107.501825. Epub 2008 Apr 17. Stroke. 2008. PMID: 18420954 Review.
• Burden of comorbidities among patients with atrial fibrillation.

  LaMori JC, Mody SH, Gross HJ, daCosta DiBonaventura M, Patel AA, Schein JR, Nelson WW. LaMori JC, et al. Ther Adv Cardiovasc Dis. 2013 Apr;7(2):53-62. doi: 10.1177/1753944712464101. Epub 2012 Oct 22. Ther Adv Cardiovasc Dis. 2013. PMID: 23090783